Literature DB >> 26476632

Food supplementation with rice bran enzymatic extract prevents vascular apoptosis and atherogenesis in ApoE-/- mice.

C Perez-Ternero1, M D Herrera2, U Laufs3, M Alvarez de Sotomayor2, C Werner3.   

Abstract

PURPOSE: Atherosclerosis is associated with reduced mononuclear cell (MNC) telomere length, and senescent cells have been detected in atherosclerotic plaques. Rice bran is a source of γ-oryzanol, phytosterols and tocols with potential lipid-lowering, antioxidant and anti-inflammatory activities. Here, we tested the hypothesis that rice bran enzymatic extract (RBEE) impacts on apoptosis, telomere length and atherogenesis in mice.
METHODS: Seven-week-old male ApoE-/- mice were fed high-fat diet (HFD) or isocaloric HFD supplemented with 5 % (w/w) RBEE for 23 weeks. Wild-type mice of the same age were kept under standard diet as controls.
RESULTS: RBEE treatment reduced total cholesterol (19.24 ± 1.63 vs 24.49 ± 1.71 mmol/L) and triglycerides (1.13 ± 0.18 vs 1.75 ± 0.22 mmol/L) and augmented HDL-cholesterol (1.86 ± 0.20 vs 1.07 ± 0.20 mmol/L). RBEE attenuated macrophage infiltration by 56.69 ± 4.65 % and plaque development (7737 ± 836 vs 12,040 ± 1001 μm2) in the aortic sinus. In the aorta, RBEE treatment reduced expression of the apoptosis pathway components p16, p53 and bax/bcl-2 ratio. RBEE prevented apoptosis of aortic endothelial cells (2.81 ± 0.71-1.14 ± 0.35 apoptotic nuclei/ring for ApoE-/- HFD and ApoE-/- HFD 5 % RBEE, respectively). In contrast, MNC of RBEE-fed mice exhibited enhanced apoptosis marker expression with increased p53 and bax/bcl-2 protein levels. Compared to WT, ApoE-/- mice on HFD were characterized by significant telomere shortening in aorta (11 ± 2 %) and MNC (73 ± 7 %), which was reduced by supplementation with RBEE (aorta: 40 ± 7 %; MNC: 105 ± 10 %). Expression of telomere repeat-binding factor 2 was increased in RBEE-fed mice.
CONCLUSION: Long-term food supplementation with RBEE lowers cholesterol and prevents atherosclerotic plaque development in ApoE-/- mice. Differential regulation of vascular and MNC apoptosis and senescence were identified as potential mechanisms.

Entities:  

Keywords:  ApoE−/−; Apoptosis; Atherosclerosis; Inflammation; Rice bran enzymatic extract; Telomeres

Mesh:

Substances:

Year:  2015        PMID: 26476632     DOI: 10.1007/s00394-015-1074-z

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  47 in total

1.  Hypocholesterolemic effect of physically refined rice bran oil: studies of cholesterol metabolism and early atherosclerosis in hypercholesterolemic hamsters.

Authors:  Lynne M Ausman; Ni Rong; Robert J Nicolosi
Journal:  J Nutr Biochem       Date:  2005-09       Impact factor: 6.048

2.  Circulating leukocyte and carotid atherosclerotic plaque telomere length: interrelation, association with plaque characteristics, and restenosis after endarterectomy.

Authors:  Jardi Huzen; Wouter Peeters; Rudolf A de Boer; Frans L Moll; Liza S M Wong; Veryan Codd; Dominique P V de Kleijn; Bart J G L de Smet; Dirk J van Veldhuisen; Nilesh J Samani; Wiek H van Gilst; Gerard Pasterkamp; Pim van der Harst
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-03-03       Impact factor: 8.311

3.  Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis.

Authors:  Christian Werner; Christoph Gensch; Janine Pöss; Judith Haendeler; Michael Böhm; Ulrich Laufs
Journal:  Atherosclerosis       Date:  2011-02-17       Impact factor: 5.162

4.  Association between telomere length in blood and mortality in people aged 60 years or older.

Authors:  Richard M Cawthon; Ken R Smith; Elizabeth O'Brien; Anna Sivatchenko; Richard A Kerber
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

5.  Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis.

Authors:  Christian Werner; Milad Hanhoun; Thomas Widmann; Andrey Kazakov; Alexander Semenov; Janine Pöss; Johann Bauersachs; Thomas Thum; Michael Pfreundschuh; Patrick Müller; Judith Haendeler; Michael Böhm; Ulrich Laufs
Journal:  J Am Coll Cardiol       Date:  2008-08-05       Impact factor: 24.094

Review 6.  The roles of senescence and telomere shortening in cardiovascular disease.

Authors:  Frej Fyhrquist; Outi Saijonmaa; Timo Strandberg
Journal:  Nat Rev Cardiol       Date:  2013-03-12       Impact factor: 32.419

7.  Microvascular disorders in obese Zucker rats are restored by a rice bran diet.

Authors:  M L Justo; C Claro; E Vila; M D Herrera; R Rodriguez-Rodriguez
Journal:  Nutr Metab Cardiovasc Dis       Date:  2013-12-01       Impact factor: 4.222

8.  Prevention of brain protein and lipid oxidation elicited by a water-soluble oryzanol enzymatic extract derived from rice bran.

Authors:  Juan Parrado; Esther Miramontes; María Jover; José Carlos Márquez; María Angeles Mejias; Laura Collantes De Teran; E Absi; Juan Bautista
Journal:  Eur J Nutr       Date:  2003-12       Impact factor: 5.614

9.  Rice bran enzymatic extract restores endothelial function and vascular contractility in obese rats by reducing vascular inflammation and oxidative stress.

Authors:  Maria Luisa Justo; Manila Candiracci; Ana Paula Dantas; Maria Alvarez de Sotomayor; Juan Parrado; Elisabet Vila; Maria Dolores Herrera; Rosalia Rodriguez-Rodriguez
Journal:  J Nutr Biochem       Date:  2013-03-01       Impact factor: 6.048

10.  Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population.

Authors:  A Baragetti; J Palmen; K Garlaschelli; L Grigore; F Pellegatta; E Tragni; A L Catapano; S E Humphries; G D Norata; P J Talmud
Journal:  J Intern Med       Date:  2014-07-19       Impact factor: 8.989

View more
  1 in total

Review 1.  Rice Bran Derived Bioactive Compounds Modulate Risk Factors of Cardiovascular Disease and Type 2 Diabetes Mellitus: An Updated Review.

Authors:  Nancy Saji; Nidhish Francis; Lachlan J Schwarz; Christopher L Blanchard; Abishek B Santhakumar
Journal:  Nutrients       Date:  2019-11-12       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.